Mechanism of BET Proteins in Th17 Cell Differentiation

    Project Details

    Description

    PROJECT SUMMARY This administrative supplement application is submitted for the parent award (5R01AI124465) in response to NIAID?s Notice of Special Interest (NOT-AI-20-031) ?Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)?, as well as ?Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp - Clinical Trial Optional)? (PA-18-591). The outbreak of the new coronavirus (SARS-CoV-2) infection is spreading to every continent around the world at an astonishing speed. As of April 15, 2020, coronavirus disease 2019 (COVID-19) has been confirmed in 2,035,764 people worldwide, causing a mortality of 6.42%, exceeding far beyond a mortality rate of
    StatusFinished
    Effective start/end date10/03/1628/02/21

    Funding

    • National Institute of Allergy and Infectious Diseases: $423,750.00
    • National Institute of Allergy and Infectious Diseases: $423,750.00
    • National Institute of Allergy and Infectious Diseases: $419,789.00
    • National Institute of Allergy and Infectious Diseases: $2,881,453.00
    • National Institute of Allergy and Infectious Diseases: $423,750.00
    • National Institute of Allergy and Infectious Diseases: $342,914.00
    • National Institute of Allergy and Infectious Diseases: $423,750.00

    Fingerprint

    Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.